Health secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdated ...
As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.
Amid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that was once readily available ...
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news ...
Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news form Morning Rounds ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
It wasn’t until he started medical school, Brian Zhang writes, that he realized ‘Asian glow’ from drinking was a sign of something important.
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with ...